Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Dev Neurosci ; 22(3): 137-47, 2004 May.
Article in English | MEDLINE | ID: mdl-15140467

ABSTRACT

Antiepileptic drugs acting through the potentiation of GABA-ergic pathways have harmful effects on brain development. Increased risk of impaired intellectual development was reported in children born to women treated for epilepsy during pregnancy. Here we examined the vulnerability of the developing brain to treatment with one of the new antiepileptic drugs--vigabatrin--during two time periods in newborn mice (postnatal days 1-7 and 4-14) which parallel the third trimester of human embryo brain development. Delayed development of sensory and motor reflexes, reduced mobility in the open field, impaired object recognition and deficient spatial learning and memory were observed independently of the treatment period. On the contrary, specific susceptibility to the age of exposure was detected in various motor functions. A number of morphological correlates may explain these behavioral alterations; a transient increase in CA1 pyramidal cell layer (P < 0.001) and decrease in granular cell layer (P < 0.05) in hippocampus were detected at postnatal day 7. In addition, a significantly lower cell density was observed in the adult mouse brain in all layers of the M2 cerebral cortex of mice treated during days 4-14, compared to the controls (P < 0.05). Our findings demonstrated short- and long-term deleterious effects of vigabatrin treatment and suggest a specific vulnerability of the developing motor system to GABA enhancement during the first postnatal week.


Subject(s)
Anticonvulsants/adverse effects , Hippocampus/drug effects , Hippocampus/pathology , Psychomotor Disorders/chemically induced , Psychomotor Disorders/pathology , Psychomotor Performance/drug effects , Vigabatrin/adverse effects , 4-Aminobutyrate Transaminase/antagonists & inhibitors , Animals , Animals, Newborn , Hippocampus/embryology , Hippocampus/growth & development , Mice , Mice, Inbred BALB C , Psychomotor Disorders/diagnosis , Psychomotor Disorders/embryology
2.
Cereb Cortex ; 14(1): 97-105, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14654461

ABSTRACT

Tumor necrosis factor alpha (TNFalpha) is a cytokine produced mainly by cells of the immune system. It is also expressed by brain neurons and glia. The physiological role of TNFalpha in the brain is not yet fully clear. Using TNFalpha-deficient mice, we have examined its role in hippocampal development and function. We report here that TNFalpha is involved in the regulation of morphological development in the hippocampus. TNFalpha-deficient mice exhibited an accelerated maturation of the dentate gyrus region and smaller dendritic trees in CA1 and CA3 regions in young mouse. In addition to its involvement in hippocampal morphogenesis, TNFalpha deficiency specifically improved performance of affected mice in behavioral tasks related to spatial memory. Moreover, lack of TNFalpha increased the expression of nerve growth factor (NGF), but not brain-derived neurotrophic factor (BDNF), following performance of the learning task. Our results suggest that TNFalpha actively influences hippocampal development and function. In adult mice, TNFalpha may interfere with memory consolidation, perhaps by regulating NGF levels.


Subject(s)
Hippocampus/growth & development , Tumor Necrosis Factor-alpha/physiology , Aging/physiology , Animals , Animals, Newborn , Brain-Derived Neurotrophic Factor/metabolism , Dendrites/physiology , Dentate Gyrus/physiology , Enzyme-Linked Immunosorbent Assay , Hippocampus/physiology , Immunohistochemistry , Maze Learning/physiology , Memory/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/physiology , Nerve Growth Factor/metabolism , Phenotype , Pyramidal Cells/physiology , Reflex/physiology , Tumor Necrosis Factor-alpha/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...